NEW YORK (GenomeWeb News) – The investors in Cellexus Ltd. said yesterday that they have acquired the assets of Cellexus Biosystems Plc and have formed a new management team aimed at bringing the firm’s products to market.
 
Cellexus makes single-use bioreactors and cell-based technologies for biopharmaceutical research and production. The firm said that since the asset acquisition it has “made significant design and operational improvements to the CellMaker bioreactor systems.”
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Reuters reports that UK researchers are using gene-editing tools to develop flu-resistant chickens.

Nature calls for genomics to become part of the World Health Organization's cholera surveillance approach.

Vox explores a proposal to institute a lottery system to award grant funds.

In Genome Biology this week: gut microbiome study of individuals from Tanzania and Botswana, sixth version of the Network of Cancer Genes database, and more.